Skip to main content
. 2016 Jun 14;2016:7407153. doi: 10.1155/2016/7407153

Figure 1.

Figure 1

Pioglitazone decreased plasma proinflammatory factors concentrations in patients after coronary DES implantation. The results are presented as raw data. Compared to the control group, PIO significantly reduced plasma IL-6, TNF-α, and MMP-9 concentrations by TWRMANOVA (P = 0.011, 0.008, 0.002, and 0.012, resp.). P < 0.05 compared with baseline.